Background Multiple sclerosis (MS) is a chronic disease associated with several impacts;
especially regarding patients' health-related quality of life (HRQL). EuroQol 5 Dimensions …

Objectives: To quantify life expectancy (LE), quality-adjusted life years (QALYs) and total
lifetime societal costs for a hypothetical cohort of Australians with multiple sclerosis (MS) …

Introduction Multiple sclerosis (MS) has significant financial consequences for healthcare
systems, individual patients and households, and the wider society. This study examines the …

Abstract Background Economic costs of Multiple Sclerosis (MS) in Australia were last
estimated in 2010 and are likely to have changed over time, especially given this new era of …

Background: Multiple sclerosis (MS) has a major impact on health and is a substantial
burden on patients and society. We estimated the annual costs of MS in Australia from …

OBJECTIVE: To derive robust estimates for the cost of multiple sclerosis (MS) based on a
variety of cost factors across a number of different cost perspectives. This is essential to …

Objective The reliability and validity of generic utility measures have not yet been
summarized in people with multiple sclerosis (MS). It is important to assess the psychometric …

Abstract Objectives The 29-item Multiple Sclerosis Impact Scale (MSIS-29) is a
psychometrically validated patient-reported outcome measure increasingly used in trials of …

This cost-of-illness analysis based on information from 1.549 patients in The Netherlands is
part of a Europe-wide study on the costs of multiple sclerosis (MS). The objective was to …

We performed a cross-sectional, bottom-up observational study of resource consumption
and quality of life of patients with multiple sclerosis (MS) in the United Kingdom. Three …